China’s estimated 114 million people with diabetes pose a massive challenge for China’s health policy-makers who have significantly extended health insurance coverage over the past decade. What China is doing now, what it has achieved, and what remains to be done should be of interest to health policy-makers, worldwide. We identify the challenges posed by China’s two principal strategies to tackle diabetes: (1) A short-term pilot strategy of health promotion, detection and control of chronic diseases in 265 national demonstration areas (NDAs); and (2) A long-term strategy to extend health promotion and strengthen primary care capacity and health system integration throughout China. Finally, we consider how Chinese innovations in artificial intelligence (AI) and Big Data may contribute to improving diagnosis, controlling complications and increasing access to care. Health system integration in China will require overcoming the fragmentation of a system that still places excessive reliance on local government financing. Moreover, what remains to be done resembles deeper challenges faced by healthcare systems worldwide: the need to upgrade primary care and reduce inequalities in access to health services.
National Commission of Health. Chinese National Statistical Yearbook of Health. China, Beijing: Peking Union Medical College Press; 2018.
National Commission of Health and Family Planning. Chinese National Statistical Yearbook of Health and Family Planning. China, Beijing: Peking Union Medical College Press; 2017.
Holmes D. Linong Ji: Fighting to turn the tide against diabetes in China. Lancet. 2014;383(9933):1961. doi:10.1016/S0140-6736(14)60942-9
Pan X-R, Yang W-Y, Li G-W, Liu J. Prevalence of diabetes and its risk factors in China, 1994. Diabetes Care. 1997;20(11):1664-1669. doi:10.2337/diacare.20.11.1664
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948-959. doi:10.1001/jama.2013.168118
Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515-2523. doi:10.1001/jama.2017.7596
Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090-1101. doi:10.1056/NEJMoa0908292
Hu D, Sun L, Fu P, et al. Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: the InterASIA Study. Diabetes Res Clin :Pract. 2009;84(3):288-295. doi:10.1016/j.diabres.2009.02.021
Popkin BM. Will China’s nutrition transition overwhelm its health care system and slow economic growth? Health Aff (Millwood). 2008;27(4):1064-1076. doi:10.1377/hlthaff.27.4.1064
Hu C, Jia W. Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes. 2018;67(1):3-11. doi:10.2337/dbi17-0013
Li Y, He Y, Qi L, et al. Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood. Diabetes. 2010;59(10):2400-2406. doi:10.2337/db10-0385
van Abeelen AF, Elias SG, Bossuyt PM, et al. Famine exposure in the young and the risk of type 2 diabetes in adulthood. Diabetes. 2012;61(9):2255-2260. doi:10.2337/db11-1559
Fuentes S, Fosse-Edorh S, Regnault N, Goldberg M, Cosson E. Prevalence of Prediabetes and Undiagnosed Diabetes among Adults Aged 18 to 70 Years in France—The CONSTANCES Cohort. Diabetes 2018; 67(suppl 1). doi:10.2337/db18-1657-P
Zhou M, Astell-Burt T, Bi Y, et al. Geographical variation in diabetes prevalence and detection in China: multilevel spatial analysis of 98,058 adults. Diabetes Care. 2015;38(1):72-81. doi:10.2337/dc14-1100
Bi Y, Wang L, Xu Y, et al. Diabetes-related metabolic risk factors in internal migrant workers in China: a national surveillance study. Lancet Diabetes Endocrinol. 2016;4(2):125-135. doi:10.1016/S2213-8587(15)00366-6
Su X. Migrant workers’ utilization of health services: Shanghai as an example. School of Social Development and Public Policy, Fudan University; 2012.
Bragg F, Holmes MV, Iona A, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China. JAMA. 2017;317(3):280-289.
Chan M. China’s burgeoning epidemic of diabetes-associated mortality. JAMA. 2017;317(3):264-266.
Li J, Li J, Zhang J, et al. Study on the overall implementation status of the National Demonstration Areas for Comprehensive Prevention and Control of Non-communicable Diseases. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39 (4):417-421. doi:10.3760/cma.j.issn.0254-6450.2018.04.006
Jin R, Li J, Zhang J, et al. Management programs on diabetes among Chinese adults in the National Demonstration Areas for Comprehensive Prevention and Control of Non-communicable Diseases. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(4):407-411. doi:10.3760/cma.j.issn.0254-6450.2018.04.004
Li B. Director of National Committee of Health and Family Planning, Li Bin: Four Models of Medical Partnerships. http://www.sohu.com/a/128570598_452205. Published 2017.
Li X, Lu J, Hu S, et al. The primary health-care system in China. Lancet. 2017;390(10112):2584-2594. doi:10.1016/S0140-6736(17)33109-4
OECD. Health care resources, OECD Health Statistics (database). Primary care and nurse workforce. doi:10.1787/data-00541-en. Published 2016.
Zhu J, Li W, Chen L. Doctors in China: improving quality through modernisation of residency education. Lancet. 2016;388(10054):1922-1929. doi:10.1016/S0140-6736(16)00582-1
Dankwa-Mullan I, Rivo M, Sepulveda M, Park Y, Snowdon J, Rhee K. Transforming diabetes care through artificial intelligence: the future is here. Popul Health Manag. 2019;22(3):229-242. doi:10.1089/pop.2018.0129
Fagherazzi G, Ravaud P. Digital diabetes: Perspectives for diabetes prevention, management and research. Diabetes Metab. 2019;45(4):322-329. doi:10.1016/j.diabet.2018.08.012
Luo,Z. , Fabre,G. and Rodwin,V. G. (2020). Meeting the Challenge of Diabetes in China. International Journal of Health Policy and Management, 9(2), 47-52. doi: 10.15171/ijhpm.2019.80
MLA
Luo,Z. , , Fabre,G. , and Rodwin,V. G. . "Meeting the Challenge of Diabetes in China", International Journal of Health Policy and Management, 9, 2, 2020, 47-52. doi: 10.15171/ijhpm.2019.80
HARVARD
Luo Z., Fabre G., Rodwin V. G. (2020). 'Meeting the Challenge of Diabetes in China', International Journal of Health Policy and Management, 9(2), pp. 47-52. doi: 10.15171/ijhpm.2019.80
CHICAGO
Z. Luo, G. Fabre and V. G. Rodwin, "Meeting the Challenge of Diabetes in China," International Journal of Health Policy and Management, 9 2 (2020): 47-52, doi: 10.15171/ijhpm.2019.80
VANCOUVER
Luo Z., Fabre G., Rodwin V. G. Meeting the Challenge of Diabetes in China. IJHPM, 2020; 9(2): 47-52. doi: 10.15171/ijhpm.2019.80